2-(BROMODIFLUOROMETHYL)BENZO[D]THIAZOLE
- $367 - $1284.41
- Product name: 2-(BROMODIFLUOROMETHYL)BENZO[D]THIAZOLE
- CAS: 235781-28-9
- MF: C8H4BrF2NS
- MW: 264.09
- EINECS:
- MDL Number:MFCD09264133
- Synonyms:2-(BROMODIFLUOROMETHYL)BENZO[D]THIAZOLE;2-(BROMODIFLUOROMETHYL)-BENZOTHIAZOLE;2-(1-bromodifluoromethyl)-1,3-benzo-thiazole;Benzothiazole, 2-(bromodifluoromethyl)-
4 prices
Selected condition:
Brand
- Alichem
- American Custom Chemicals Corporation
- Crysdot
Package
- 5MG
- 1g
- 5g
- ManufacturerAlichem
- Product number235781289
- Product description2-(Bromodifluoromethyl)benzo[d]thiazole
- Packaging5g
- Price$1284.41
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number235781289
- Product description2-(Bromodifluoromethyl)benzo[d]thiazole
- Packaging1g
- Price$416
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0353085
- Product description2-(BROMODIFLUOROMETHYL)BENZO[D]THIAZOLE 95.00%
- Packaging5MG
- Price$497.93
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11161237
- Product description2-(Bromodifluoromethyl)benzo[d]thiazole 97%
- Packaging1g
- Price$367
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 235781289 | 2-(Bromodifluoromethyl)benzo[d]thiazole | 5g | $1284.41 | 2021-12-16 | Buy |
Alichem | 235781289 | 2-(Bromodifluoromethyl)benzo[d]thiazole | 1g | $416 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0353085 | 2-(BROMODIFLUOROMETHYL)BENZO[D]THIAZOLE 95.00% | 5MG | $497.93 | 2021-12-16 | Buy |
Crysdot | CD11161237 | 2-(Bromodifluoromethyl)benzo[d]thiazole 97% | 1g | $367 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|